Biomarkers for efficacy of adjuvant chemotherapy following complete resection in NSCLC stages I–IIIA
Biomarkers may be useful when deciding which nonsmall cell lung cancer (NSCLC) patients may benefit from adjuvant chemotherapy following complete resection and which chemotherapeutic agents may be used preferably in individual patients in order to maximise survival. A literature search covering the...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2015-06-01
|
| Series: | European Respiratory Review |
| Online Access: | http://err.ersjournals.com/content/24/136/340.full |